# A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

> **NCT00220922** · PHASE4 · COMPLETED · sponsor: **Teva Neuroscience, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **PROCEDURE:** Alcohol Wipes vs. No Alcohol Wipes

## Key facts

- **NCT ID:** NCT00220922
- **Lead sponsor:** Teva Neuroscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** 2005-10
- **Final completion:** 2006-02
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220922, "A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00220922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*